{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:34:17Z","timestamp":1756190057054},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12471-015-0652-2","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T12:38:09Z","timestamp":1422362289000},"page":"153-160","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions"],"prefix":"10.1007","volume":"23","author":[{"given":"Cordula","family":"Felix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Diletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Daemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"de Jaegere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Regar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihan","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert-Jan M.","family":"van Geuns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"issue":"1","key":"652_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193\u2013202.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"652_CR2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","volume":"35","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P. Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J. 2014;35(12):765\u201376.","journal-title":"Eur Heart J"},{"issue":"19","key":"652_CR3","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1161\/CIRCULATIONAHA.110.000901","volume":"125","author":"S Nishio","year":"2012","unstructured":"Nishio S, Kosuga K, Igaki K, et al. Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents. Circulation. 2012;125(19):2343\u201353.","journal-title":"Circulation"},{"issue":"20","key":"652_CR4","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001\u201315.","journal-title":"N Engl J Med"},{"issue":"2","key":"652_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12471-013-0472-1","volume":"22","author":"T Yetgin","year":"2014","unstructured":"Yetgin T, van der Linden MM, de Vries AG, et al. Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes. Neth Heart J. 2014;22(2):55\u201361.","journal-title":"Neth Heart J"},{"key":"652_CR6","doi-asserted-by":"crossref","unstructured":"Verheye S, Ormiston JA, Stewart J, et al. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation 6-and 12-month clinical and multimodality imaging results. JACC Cardiovasc Interv. 2014;7(1):89\u201399.","DOI":"10.1016\/j.jcin.2013.07.007"},{"key":"652_CR7","doi-asserted-by":"crossref","unstructured":"Everaert B, Felix C, Koolen J, et al. Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users. A position statement on the use of bioresorbable vascular scaffolds in the Netherlands. Neth Heart J. [Recommendation]. 2015. doi:10.1007\/s12471-015-0651-3.","DOI":"10.1007\/s12471-015-0651-3"},{"issue":"9667","key":"652_CR8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","volume":"373","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Ormiston JA, Onuma Y, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373(9667):897\u2013910.","journal-title":"Lancet"},{"issue":"10","key":"652_CR9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","volume":"6","author":"Y Onuma","year":"2013","unstructured":"Onuma Y, Dudek D, Thuesen L, et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc Interv. 2013;6(10):999\u20131009.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"652_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ccd.21136","volume":"70","author":"S Tanimoto","year":"2007","unstructured":"Tanimoto S, Serruys PW, Thuesen L, et al. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv. 2007;70(4):515\u201323.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"652_CR11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4244\/EIJV9I11A217","volume":"9","author":"PW Serruys","year":"2014","unstructured":"Serruys PW, Onuma Y, Garcia-Garcia HM, et al. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention. 2014;9(11):1271\u201384.","journal-title":"EuroIntervention"},{"issue":"5","key":"652_CR12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCINTERVENTIONS.112.971549","volume":"5","author":"JA Ormiston","year":"2012","unstructured":"Ormiston JA, Serruys PW, Onuma Y, et al. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ Cardiovasc Interv. 2012;5(5):620\u201332.","journal-title":"Circ Cardiovasc Interv"},{"issue":"15","key":"652_CR13","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","volume":"58","author":"PW Serruys","year":"2011","unstructured":"Serruys PW, Onuma Y, Dudek D, et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol. 2011;58(15):1578\u201388.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"652_CR14","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2014.09.029","volume":"64","author":"A Karanasos","year":"2014","unstructured":"Karanasos A, Simsek C, Gnanadesigan M, et al. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. JACC. 2014;64(22):2343\u201356.","journal-title":"JACC"},{"key":"652_CR15","unstructured":"Abizaid A, Costa JR, Jr., Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, et al. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 2014 Apr 29. PubMed PMID: 24769555. Epub 2014\/04\/29. Eng."},{"key":"652_CR16","doi-asserted-by":"crossref","unstructured":"Chevalier B. An interim 12-month propensity adjusted comparison of clinical outcomes of ABSORB patients to Xience V patients. ESC. 2013.","DOI":"10.1093\/eurheartj\/eht309.2594"},{"key":"652_CR17","unstructured":"Carrie D. An interim 24-month propensity score analysis comparison of clinical outcomes of ABSORB EXTEND and ABSORB Cohort B patients to Xience V patients. EuroPCR. 2014."},{"issue":"18","key":"652_CR18","first-page":"B","volume":"62","author":"RJ. Whitbourn","year":"2013","unstructured":"Whitbourn RJ. TCT-31 ABSORB EXTEND: an interim report on the 24-month clinical outcomes from the first 250 patients enrolled. J Am Coll Cardiol. 2013;62(18_S1):B11\u2013B. doi:10.1016\/j.jacc.2013.08.761.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"652_CR19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ahj.2012.08.010","volume":"164","author":"R Diletti","year":"2012","unstructured":"Diletti R, Serruys PW, Farooq V, et al. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Am Heart J. 2012;164(5):654\u201363.","journal-title":"Am Heart J"},{"key":"652_CR20","unstructured":"Serruys PW, Chevalier B, Dudek D, Cequier A, Carrie D, Iniguez A, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet. 2014 Sep 12. PubMed PMID: 25230593. Epub 2014\/09\/19. Eng."},{"key":"652_CR21","unstructured":"Van Geuns RJ. BVS Expand: 6-month results. EuroPCR. 2014."},{"key":"652_CR22","doi-asserted-by":"crossref","unstructured":"Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention. 2014 Jul 18.","DOI":"10.4244\/EIJY14M07_11"},{"key":"652_CR23","doi-asserted-by":"crossref","unstructured":"Kraak RP, Hassell ME, Grundeken MJ, et al. Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry. EuroIntervention. 2014 Aug 20.","DOI":"10.4244\/EIJY14M08_08"},{"key":"652_CR24","doi-asserted-by":"crossref","unstructured":"Costopoulos C, Latib A, Naganuma T, et al. Comparison of early clinical outcomes between absorb bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population. Catheter Cardiovasc Interv. 2014 Jun 6.","DOI":"10.1002\/ccd.25569"},{"key":"652_CR25","unstructured":"Wohrle J, Naber C, Schmitz T, Schwencke C, Frey N, Butter C, et al. Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014 Dec 16. PubMed PMID: 25499836. Epub 2014\/12\/17. Eng."},{"key":"652_CR26","unstructured":"Eeckhout EE. Latest from ABSORB first. EuroPCR. 2014."},{"issue":"11","key":"652_CR27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s12471-014-0598-9","volume":"22","author":"BB Ijkema","year":"2014","unstructured":"Ijkema BB, Bonnier JJ, Schoors D, Schalij MJ, Swenne CA. Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation. Neth Heart J. 2014;22(11):484\u201390.","journal-title":"Neth Heart J"},{"issue":"2","key":"652_CR28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00392-013-0630-x","volume":"103","author":"J Wiebe","year":"2014","unstructured":"Wiebe J, Mollmann H, Most A, et al. Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold. Clin Res Cardiol. 2014;103(2):141\u20138.","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"652_CR29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/eurheartj\/eht546","volume":"35","author":"R Diletti","year":"2014","unstructured":"Diletti R, Karanasos A, Muramatsu T, et al. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. Eur Heart J. 2014;35(12):777\u201386.","journal-title":"Eur Heart J"},{"issue":"12","key":"652_CR30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/eurheartj\/eht545","volume":"35","author":"V Kocka","year":"2014","unstructured":"Kocka V, Maly M, Tousek P, et al. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'. Eur Heart J. 2014;35(12):787\u201394.","journal-title":"Eur Heart J"},{"issue":"9","key":"652_CR31","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4244\/EIJV9I9A176","volume":"9","author":"T Gori","year":"2014","unstructured":"Gori T, Schulz E, Hink U, et al. Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes. EuroIntervention. 2014;9(9):1036\u201341.","journal-title":"EuroIntervention"},{"key":"652_CR32","doi-asserted-by":"crossref","unstructured":"Dudek D, Rzeszutko L, Zasada W, Depukat R, Siudak Z, Ochala A, et al. Bioresorbable vascular scaffolds in patients with acute coronary syndromes : the POLAR ACS study. Polskie Archiwum Medycyny Wewnetrznej. 2014 Dec 23;124(12):669\u201377. PubMed PMID: 25563622. Epub 2015\/01\/08. eng.","DOI":"10.20452\/pamw.2550"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-015-0652-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12471-015-0652-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-015-0652-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T05:00:20Z","timestamp":1566277220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12471-015-0652-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s12471-015-0652-2","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}